Literature DB >> 4542735

Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

G D Ross, M J Polley, E M Rabellino, H M Grey.   

Abstract

IN THE PRESENT STUDY IT WAS SHOWN THAT NORMAL PERIPHERAL LYMPHOCYTES HAVE TWO DIFFERENT COMPLEMENT RECEPTORS: one for C3b (the immune adherence receptor) and one for C3b subsequent to its cleavage by C3b inactivator. The two receptors are not cross-reactive and were shown by tests with various antisera to be antigenically distinct. Both the immune adherence receptor and the receptor for C3b inactivator-cleaved C3b were found on normal peripheral lymphocytes and on cultured lymphoblastoid cells. In 15 out of 18 chronic lymphatic leukemia patients, the immune adherence receptor was either partially or completely missing from the peripheral lymphocytes, while the lymphocyte receptor for C3b inactivator-cleaved C3b was retained. Normal erythrocytes, on the other hand, were found to have only the immune adherence receptor. Granulocytes from normal peripheral blood appeared to have only a receptor for C3b and did not have a receptor for C3b inactivator-cleaved C3b.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542735      PMCID: PMC2180565          DOI: 10.1084/jem.138.4.798

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness.

Authors:  H L Spiegelberg; W O Weigle
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

2.  Immunoglobulin determinants on the surface of mouse lymphoid cells.

Authors:  M C Raff; M Sternberg; R B Taylor
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

3.  Rapid preparation of lymphocytes for tissue-typing.

Authors:  R Harris; E O Ukaejiofo
Journal:  Lancet       Date:  1969-08-09       Impact factor: 79.321

4.  Purification of lymphocytes and platelets by gradient centrifugation.

Authors:  R J Perper; T W Zee; M M Mickelson
Journal:  J Lab Clin Med       Date:  1968-11

5.  The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.

Authors:  P J Lachmann; H J Müller-Eberhard
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

6.  C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

7.  Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies.

Authors:  H Huber; S D Douglas
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

8.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  78 in total

1.  Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.

Authors:  H Okada; N Okada
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia.

Authors:  J A Tooze; D H Bevan
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

4.  Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.

Authors:  J D Lambris; V S Ganu; S Hirani; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Complement components and lymphoid cell surfaces.

Authors:  I McConnell
Journal:  Proc R Soc Med       Date:  1976-09

6.  Bone marrow-derived lymphoid cell lines from patients with agammaglobulinemia.

Authors:  J Schwaber; H Lazarus; F S Rosen
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.

Authors:  B F Haynes; G S Eisenbarth; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Surface receptors on human haematopoietic cell lines.

Authors:  C Huber; C Sundström; K Nilsson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

9.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

10.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.